Primary Myelofibrosis (PMF) Active Not Recruiting Phase 2 Trials for Itacitinib (DB12154)

Also known as: Primary Myelofibrosis / Primary Myelofibrosis (MF) / Myelofibrosis (PMF) / Myelofibrosis, Primary / PMF / Osteomyelofibrosis / Primary myelofibrosis (disorder) / Myelofibrosis (disorder) / Primary myelofibrosis (morphologic abnormality)

DBCOND0044387 (Primary Myelofibrosis (PMF))Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT04339101Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell TransplantationTreatment